lobbying_activities: 2636752

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2636752	7bdb3a53-5a69-49a1-bc1f-44c808655aa3	Q2	WAXMAN STRATEGIES	401103693	340B HEALTH	2021	second_quarter	PHA	Issues affecting the 340B drug pricing program; Appropriations for 340B program.	HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2021-07-14T11:44:52.397000-04:00